Sample-to-result molecular infectious disease assays: Clinical implications, limitations and potential

Stacy G. Beal, Naziheh Assarzadegan, Kenneth H. Rand

Research output: Contribution to journalReview articlepeer-review

Abstract

Molecular infectious disease diagnostic tests have undergone major advances in the past decade and will continue to rapidly evolve. Assays have become extraordinarily simple to perform, eliminating the need for pre-analytic sample preparation and post-amplification analysis. This allows these tests to be performed in settings without sophisticated expertise in molecular biology, including locations with limited resources. Additionally, the sensitivity and specificity of these assays is superb and many offer extremely fast turn-around times. These tests have major impacts on patient care, but also have some limitations.

Original languageEnglish (US)
Pages (from-to)323-341
Number of pages19
JournalExpert Review of Molecular Diagnostics
Volume16
Issue number3
DOIs
StatePublished - Mar 3 2016
Externally publishedYes

Keywords

  • Infectious disease testing
  • microbiology
  • molecular testing
  • nucleic acid tests
  • rapid testing
  • sample to answer
  • sample to result
  • undeveloped countries

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'Sample-to-result molecular infectious disease assays: Clinical implications, limitations and potential'. Together they form a unique fingerprint.

Cite this